SCHEMBL26129643

SCHEMBL26129643

O=C1CCCN1CC1CCNC1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DRD2 P14416 1/20 0.40
PIK3CD O00329 1/20 0.40
TSHR P16473 1/20 0.39
SLC6A1 P30531 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRB2 P47870 1/20 0.37
SLC6A12 P48065 1/20 0.37
SLC6A11 P48066 1/20 0.37
SLC6A13 Q9NSD5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3330835 0.92 DRD2 (0.47) SLC6A2SLC6A4SLC6A3KDM4EL3MBTL1
SCHEMBL255185 0.90 KDM4E (0.44) KDM4EL3MBTL1DRD2PIK3CDTSHR
Hydrochloric Acid SCHEMBL190200 0.88 KDM4E (0.43) KDM4EL3MBTL1DRD2PIK3CDTSHR
Hydrochloric Acid SCHEMBL9148103 0.87 KDM4E (0.42) KDM4EL3MBTL1DRD2PIK3CDTSHR
SCHEMBL26131264 0.85 DRD2 (0.41) KDM4EL3MBTL1DRD2
Hydrochloric Acid SCHEMBL26130653 0.83 DRD2 (0.40) SLC6A2SLC6A4SLC6A3KDM4EL3MBTL1
SCHEMBL26128730 0.83 L3MBTL1 (0.41) KDM4EL3MBTL1DRD2
SCHEMBL22340533 0.81 KDM4E (0.43) KDM4EL3MBTL1DRD2PIK3CDTSHR
SCHEMBL7384750 0.80 KDM4E (0.52) KDM4EL3MBTL1PIK3CDTSHR
SCHEMBL18860010 0.78 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3PIK3CDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4506344-A1 1,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF Bebetter Med Inc. (CN) 2025-02-12 EP disclosed
US-20250034116-A1 1,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF BEBETTER MED INC. (CN) 2025-01-30 US disclosed
CN-116615417-B 1, 4-Diheterocyclic group substituted aromatic ring or aromatic heterocyclic compound and application thereof 广州必贝特医药股份有限公司 2024-05-14 CN disclosed
WO-2023185821-A1 1,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF 广州必贝特医药股份有限公司 2023-10-05 WO disclosed
CN-116615417-A 1, 4-diheterocycle substituted aromatic ring or aromatic heterocyclic compound and application thereof 广州必贝特医药股份有限公司 2023-08-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034116-A1 1,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF CYP46A1, CYP4A22, CYP2C19 SLC6A2 4212/4885SLC6A4 3373/4885SLC6A3 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.